Class information for:
Level 1: ATAZANAVIR//RITONAVIR//LOPINAVIR

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2540 2143 33.6 74%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
26 34435 ANTIRETROVIRAL THERAPY//HIV//NEVIRAPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ATAZANAVIR Author keyword 127 62% 6% 133
2 RITONAVIR Author keyword 120 42% 10% 223
3 LOPINAVIR Author keyword 99 51% 6% 139
4 DARUNAVIR Author keyword 63 48% 4% 96
5 SAQUINAVIR Author keyword 58 41% 5% 111
6 AMPRENAVIR Author keyword 45 60% 2% 49
7 TIPRANAVIR Author keyword 39 61% 2% 42
8 NELFINAVIR Author keyword 37 35% 4% 86
9 INDINAVIR Author keyword 37 31% 5% 98
10 LOPINAVIR RITONAVIR Author keyword 27 47% 2% 43

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ATAZANAVIR 127 62% 6% 133 Search ATAZANAVIR Search ATAZANAVIR
2 RITONAVIR 120 42% 10% 223 Search RITONAVIR Search RITONAVIR
3 LOPINAVIR 99 51% 6% 139 Search LOPINAVIR Search LOPINAVIR
4 DARUNAVIR 63 48% 4% 96 Search DARUNAVIR Search DARUNAVIR
5 SAQUINAVIR 58 41% 5% 111 Search SAQUINAVIR Search SAQUINAVIR
6 AMPRENAVIR 45 60% 2% 49 Search AMPRENAVIR Search AMPRENAVIR
7 TIPRANAVIR 39 61% 2% 42 Search TIPRANAVIR Search TIPRANAVIR
8 NELFINAVIR 37 35% 4% 86 Search NELFINAVIR Search NELFINAVIR
9 INDINAVIR 37 31% 5% 98 Search INDINAVIR Search INDINAVIR
10 LOPINAVIR RITONAVIR 27 47% 2% 43 Search LOPINAVIR+RITONAVIR Search LOPINAVIR+RITONAVIR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RITONAVIR 238 38% 23% 503
2 AMPRENAVIR 164 70% 6% 137
3 SAQUINAVIR 156 49% 11% 228
4 LOPINAVIR RITONAVIR 121 43% 10% 215
5 LOW DOSE RITONAVIR 94 73% 3% 72
6 NELFINAVIR 86 39% 8% 172
7 ACTIVE METABOLITE M8 81 96% 1% 25
8 LOPINAVIR 75 55% 4% 93
9 LOPINAVIR RITONAVIR MONOTHERAPY 67 73% 2% 51
10 INDINAVIR 64 23% 11% 243

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel 2014 50 130 15%
Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel 2012 409 116 7%
The Role of Therapeutic Drug Monitoring in the Management of Patients With Human Immunodeficiency Virus Infection 2011 23 77 64%
Protease inhibitor monotherapy 2011 19 10 70%
Practical guidelines to interpret plasma concentrations of antiretroviral drugs 2004 73 35 86%
Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients 2007 56 26 69%
Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting 2013 10 21 52%
The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters 2010 62 96 34%
Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir 2005 76 47 70%
How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials 2009 29 27 74%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CLIN PHARM 533 8 75% 0.3% 6
2 PK LTD 8 100% 0.2% 5
3 I TECH SERV 6 71% 0.2% 5
4 INVEST MEDICAMENT 5 54% 0.3% 7
5 ST STEPHENS 5 14% 1.6% 35
6 INT AIDS THER Y EVALUAT 4 67% 0.2% 4
7 CLIN PHARMACOKINET PHARM 4 75% 0.1% 3
8 HIV CLIN PHARMACOL PROGRAM 4 75% 0.1% 3
9 INFECT DIS NUCI 4 75% 0.1% 3
10 HIV NETHERLANDS AUSTRALIA THAILAND ABORAT 4 24% 0.7% 15

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000258514 EFAVIRENZ//CYP2B6//NEVIRAPINE
2 0.0000217072 ETRAVIRINE//RILPIVIRINE//TMC125
3 0.0000182795 ROYAL FREE HIV MED//CD4 CELL COUNT//X BICHAT MED
4 0.0000179470 FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM
5 0.0000116363 K65R//TRANSMITTED DRUG RESISTANCE//HIV 1 DRUG RESISTANCE
6 0.0000105687 NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY
7 0.0000099164 ZIDOVUDINE//AZT//DIDANOSINE
8 0.0000072661 EARLY INFANT DIAGNOSIS//SINIKITHEMBA CLIN//INFANT DIAGNOSIS
9 0.0000072653 HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN
10 0.0000067734 LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB